ArticleCancers2024

Availability and Access to Orphan Drugs for Rare Cancers in Bulgaria: Analysis of Delays and Public Expenditures.

Kostadin Kostadinov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.